Atlas Trials

Empirical Intravenous Beta-Lactam Plus Metronidazole Vs Oral Cefixime Plus Metronidazole for the Treatment of Liver Abscess

Clinical trial NCT06847126 · RECRUITING

Trial details

NCT number
NCT06847126
Sponsor
Post Graduate Institute of Medical Education and Research, Chandigarh
Status
RECRUITING
Phase
Phase 3
Study type
INTERVENTIONAL
Liver Abscess
Start date
2025-02-25
Primary completion
2026-06-30
Enrollment
220

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.